Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Nutr ; 56(5): 1993-2002, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27743130

RESUMO

PURPOSE: Alcoholic liver disease or non-alcoholic fatty liver disease/non-alcoholic steatohepatitis are well-known risk factors for liver fibrosis or cirrhosis and hepatocellular carcinoma; it is a major global health concern, but there are few effective and safe management options. Therefore, we aimed to investigate the effects of fermented garlic extracts (FGEs) on hepatic function in adults with mild hepatic dysfunction without underlying hepatic disease. METHODS: In this double-blind, randomized, placebo-controlled study, seventy-five adults with elevated serum gamma-glutamyl transpeptidase (GGT) levels were included in a FGE-administered group (n = 36) or a placebo group (n = 39), and received either two sachets/day containing FGEs or placebo over a 12-week period. Primary endpoint was the change in serum GGT levels. Data were analysed using a generalized linear mixed effects model. RESULTS: Significant group × time interactions for serum levels of GGT (F = 3.98, P = 0.022) and alanine aminotransferase (ALT; F = 3.28, P = 0.043) were observed with an improvement in levels of GGT (P = 0.066) and ALT (P = 0.014) in the FGE group compared to that reported for the placebo group at the 12-week visits. There was no intergroup difference in the prevalence of adverse events. CONCLUSIONS: Intake of FGEs improved serum GGT and ALT levels in adults with mildly elevated serum GGT level without reported adverse side effects. FGEs might be effective and safe management options for mild hepatic dysfunction.


Assuntos
Fermentação , Alho , Fígado/fisiologia , gama-Glutamiltransferase/sangue , Adulto , Idoso , Alanina Transaminase/sangue , Antioxidantes/farmacologia , Povo Asiático , Aspartato Aminotransferases/sangue , Colesterol/sangue , Dieta , Método Duplo-Cego , Determinação de Ponto Final , Exercício Físico , Feminino , Manipulação de Alimentos , Humanos , Hepatopatias/sangue , Hepatopatias/prevenção & controle , Masculino , Pessoa de Meia-Idade , Tamanho da Amostra , Fatores Socioeconômicos , Triglicerídeos/sangue
2.
Neuroreport ; 20(1): 69-73, 2009 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-19057282

RESUMO

Although manganese (Mn) has been shown to increase prolactin (PRL) by decreasing dopamine (DA) in the hypothalamus, the mechanism of Mn-induced regulation of the hypothalamic-hypophyseal-pituitary axis is unclear. We assessed the effects of inhaled Mn on hypothalamic DA and pituitary PRL production and evaluated the role of pituitary-specific transacting factor 1 (Pit-1), a transacting factor of PRL gene, in Mn-induced changes in PRL secretion in the rat brain. Male rats exposed to Mn for 4 or 13 weeks (1.5 mg/m3, 6 h/day, 5 days/week) showed a progressive and significant decrease in hypothalamic DA, whereas PRL and Pit-1 mRNA levels increased in response to Mn exposure. These results suggest that exposure to Mn decreases hypothalamic DA and promotes the production of PRL in the pituitary and that Pit-1 might be a regulator of DA and PRL.


Assuntos
Dopamina/metabolismo , Compostos de Manganês/farmacologia , Prolactina/metabolismo , Sulfatos/farmacologia , Animais , Northern Blotting , Cromatografia Líquida de Alta Pressão , Dopamina/análise , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Masculino , Compostos de Manganês/administração & dosagem , Hipófise/efeitos dos fármacos , Hipófise/metabolismo , Prolactina/sangue , Prolactina/genética , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Radioimunoensaio , Ratos , Ratos Endogâmicos F344 , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sulfatos/administração & dosagem , Fatores de Tempo , Oligoelementos/administração & dosagem , Oligoelementos/farmacologia , Fator de Transcrição Pit-1/genética , Fator de Transcrição Pit-1/metabolismo
3.
Mol Cells ; 22(1): 30-5, 2006 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-16951547

RESUMO

Munc18, a mammalian homolog of C. elegans Unc, is essential for neurotransmitter release. The aim of this study was to identify estrogen-dependent expression of Munc18-1 and its role in the regulation of glutamate release for puberty onset. Hypothalamic munc18-1 mRNA levels were significantly increased by estrogen treatment in ovariectomized, immature female rats. During pubertal development, the munc18-1 mRNA levels dramatically increased between the juvenile period and the anestrous phase of puberty. Intracerebroventricular administration of an antisense oligodeoxynucleotide against munc18-1 mRNA significantly decreased glutamate release and delayed the day of puberty onset. These results suggest that Munc18-1, expressed in an estrogen-dependent manner, plays an important role in the onset of female puberty via the regulation of glutamate release.


Assuntos
Ácido Glutâmico/metabolismo , Proteínas Munc18/fisiologia , Animais , Estradiol/farmacologia , Feminino , Hipotálamo/metabolismo , Proteínas Munc18/genética , Oligodesoxirribonucleotídeos Antissenso/farmacologia , Ovariectomia , Ovário/fisiologia , Ratos
4.
Biol Pharm Bull ; 28(6): 1016-20, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15930737

RESUMO

Ischaemic stroke is a leading cause of death and long-lasting disability. Gastrodia elata blume (GEB) is a Chinese herb that is widely used to treat convulsive disorders, such as epilepsy, and p-hydroxybenzyl alcohol (HBA) is the active ingredient in GEB. The present study was conducted to evaluate the effects of GEB and HBA on the brain damage and transcriptional levels of Protein disulfide isomerase (PDI) and 1-Cys peroxiredoxin (1-Cys Prx) genes known to play a role in antioxidant systems after transient focal ischemia in the rat brain. Focal ischemia was induced in rats by middle cerebral artery occlusion (MCAO). All animals underwent ischemia for 1 h, followed by 24 h of reperfusion. Coronal brain slices were stained with 2,3,5-triphenyltetrazolium chloride or total RNA was extracted for the analysis of gene expression. Histopathologic analysis revealed a significant (p<0.05) decrease in infarct size in the ipsilateral brain with GEB extracts or HBA. Moreover, the levels of PDI and 1-Cys Prx transcription were significantly increased in the GEB extract- or HBA-treated group compared with the untreated group (p<0.05). This study therefore indicated that GEB and HBA provide neuroprotection by preventing brain damage through the increased expression of genes encoding antioxidant proteins after transient focal cerebral ischemia and may be effective as neuroprotective agents at the cellular and molecular levels in the brain.


Assuntos
Antioxidantes/metabolismo , Álcoois Benzílicos/uso terapêutico , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/metabolismo , Gastrodia , Regulação da Expressão Gênica/efeitos dos fármacos , Animais , Álcoois Benzílicos/isolamento & purificação , Álcoois Benzílicos/farmacologia , Isquemia Encefálica/patologia , Regulação da Expressão Gênica/fisiologia , Masculino , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacocinética , Extratos Vegetais/uso terapêutico , Ratos , Ratos Sprague-Dawley
5.
J Prev Med Public Health ; 37(2): 157-65, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-25178447

RESUMO

OBJECTIVE: This study aimed to investigate the toxic effects of chromium (VI) on the placental function and reproduction in rats. For the study, the placental prolactin-growth hormone (PRL-GH) gene expression, placental trophoblast cell differentiation and reproductive data were analyzed. METHODS: The pregnancies of F344 Fisher rats were checked by the presence of a copulatory plug or sperm in the vaginal smear, which was defined as day 0 of the pregnancy. Pregnant rats were divided into the three groups. The control group was given tap water (chromium level < 0.001 ppm) and the remaining groups were given 250 or 750 ppm of chromium (VI) [as potassium dichromate], from day 7 to 19 of the pregnancy. Rats were sacrificed at days 11 and 20 of pregnancy. The mRNA levels of PRL-GH and Pit-1a and b isotype genes were analyzed by Northern blot hybridization and reverse transcriptionpolymerase chain reaction (RT-PCR). The hormonal concentration was analyzed by radioimmunoassay, and the differentiation of placental trophoblast cells were observed by histochemical studies. Reproductive data, such as placental and fetal weights, pregnancy period, and litter size, were surveyed at day 20 of pregnancy and after birth. A statistical analysis was carried out using the SAS program (version 8.1). RESULTS: The mRNA levels of the prolactin-growth hormone (PRL-GH) family of genes were dose dependently reduced by chromium exposure. The mRNA levels of Pit-1a and b isotype genes that induce the expression of the PRL-GH family of genes were also reduced by chromium exposure. The PRL-GH hormonal concentration in the rat placenta, fetus and maternal blood were decreased by chromium exposure. In the middle stage of pregnancy (day 11), a high dose of chromium suppressed the differentiation of spongiotrophoblast cells that secret the PRLGH hormones. In the last stage of pregnancy (day 20), a high dose of chromium induced apoptosis of placental cells. Reproductive data, such as placental and fetal weights, litter size, were reduced, but the pregnancy period was extended in the group exposed to chromium compared with the controls. CONCLUSIONS: Chromium (VI) disrupts the ordered functions of the placenta, which leads to reproductive disorders in rats.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA